Aussie levfin tested with two syndications
Australia’s leveraged markets received a rare test this week — and passed with flying colours as Study Group closed an oversubscribed A$330m ($300m) deal on Tuesday and paved the way for Healthscope’s A$1.5bn loan to hit syndication next week.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts